Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

PBM remuneration in Medicare Part D must move away from list price–linked, percentage-based compensation and historic rebate-centered models, altering incentives across formulary, contracting, and ...

Just over 56 million people are enrolled in Medicare Part D, with the share of those securing coverage through Medicare Advantage Prescription Drug (MAPD) plans growing alongside the overall program.

As the Centers for Medicare & Medicaid Services adjust regulations for the upcoming fiscal cycle, beneficiaries face a shifting landscape in healthcare expenses that alters how monthly budgets are ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage. Such drug plans are used ...

The Centers for Medicare & Medicaid Services is seeking comments by May 11 on its proposed revisions to data reporting requirements for Medicare Advantage and Part D plans, according to a Paperwork ...

Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Medicare enrollees who buy the ...

As we approach 2026, Medicare beneficiaries need to be aware of upcoming changes to Part D, the private prescription drug coverage. While some crucial figures have already been confirmed and finalized ...

Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall. The number of available, stand-alone drug plans has fallen for a few years, and that trend will ...

Retiring early creates a rare tax window most people miss. Here’s how Roth conversions during the gap years can work in your ...

Add Yahoo as a preferred source to see more of our stories on Google. Guests attend a rally at the U.S. Capitol on May 6 to support research and policies for breast cancer treatment that are at risk ...